# CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease

> **NCT05257967** · NA · RECRUITING · sponsor: **British Columbia Cancer Agency** · enrollment: 10 (estimated)

## Conditions studied

- EGFR Activating Mutation
- Leptomeningeal Metastasis
- Non Small Cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Lumbar puncture and Phlebotomy

## Key facts

- **NCT ID:** NCT05257967
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-18
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05257967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05257967, "CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05257967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*